市場調査レポート

商品コード

過活動膀胱治療の2028年までの市場予測-薬物療法および疾患タイプ別の世界分析

Overactive Bladder Treatment Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Pharmacotherapy and Disease Type

出版日: 2022年10月21日 | 発行: The Insight Partners

| ページ情報: 英文 209 Pages | 納期: 即納可能

価格

PDF (Single User License)

USD 4,550 704,977円

レポートPDFを1名のみがご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷は一度のみ可能です。印刷したもののご利用はPDFのライセンス保持者に限定されます。

PDF (Site License)

USD 6,550 1,014,857円

レポートPDFを同一事業所（所在地）内のすべての方にご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷回数に制限はありません。印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF (Enterprise License)

USD 8,550 1,324,737円

レポートPDFを企業内すべての方に使用頂けるライセンスです。PDF内のテキスト等のコピーは可能です。PDFの印刷回数に制限はありません。印刷したもののご利用はPDFのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=154.94円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

過活動膀胱治療の世界市場は、2021年の42億9593万米ドルから、2028年には53億3392万米ドルに拡大すると予測されています。2022年から2028年にかけてはCAGR3.1％で成長すると推定されます。

過活動膀胱（OAB）とは、頻繁かつ突然の尿意を催し、そのコントロールが困難な場合があることを指します。OABは、腹部外傷、感染症、神経損傷、特定の薬剤などが原因で引き起こされることがあります。OABは65歳以上の高齢者によくみられます。女性は45歳以降にOABを発症することがあります。治療には、特定の行動を変えること、薬物療法、神経刺激などがあります。全米失禁協会のデータによると、2018年、世界中で～2億人が尿失禁の影響を受けています。女性に影響を与える尿失禁には、ストレス性尿失禁と切迫性尿失禁があり、後者は過活動膀胱とも呼ばれます。

同様に、2020年に米国医師会および米国感染症学会の研究者グループが行った調査では、米国では毎年、尿路感染症（UTI）が原因で約600万人の医師が受診していると述べられています。カナダでは、年間～50万人がUTIの診察のために医師のオフィスを訪れています。カナダでは、UTIは外来診療所および救急診療所の受診理由として、それぞれ8番目と5番目に多い理由となっています。このように、尿失禁の有病率の増加と尿路感染症の発生率の増加が、過活動膀胱治療市場を牽引しています。

過活動膀胱治療市場は、薬物療法、疾患タイプ、地域に分類されます。地域別では、北米、欧州、アジア太平洋地域、中東・アフリカ、中南米に大別されます。過活動膀胱治療市場レポートでは、市場動向、市場力学、世界の主要な市場プレイヤーの競合分析などのパラメータを強調し、市場の考察と詳細な分析を提供します。

薬物療法に基づき、過活動膀胱治療市場はミラベグロン、ボトックス、神経刺激、抗コリン剤、膀胱内注入に区分されます。ミラベグロンセグメントは2021年に市場で最大のシェアを占め、予測期間中に最も高いCAGRを記録すると予測されます。ミラベグロンは、成人の過活動膀胱の治療に単独またはソリフェナシンと共に使用されます。また、3歳以上の小児における神経因性十字膀胱過活動（脳、脊髄、神経の問題によって起こる膀胱の制御状態）の治療にも使用されます。ミラベグロンは、β3アドレナリン作動薬と呼ばれる薬剤の一種に属します。膀胱の筋肉を弛緩させ、切迫した頻尿や無秩序な排尿を防止します。ミラベグロンには、経口投与可能な徐放錠（長時間作用型）および徐放性懸濁液があります。2022年10月、ザイダス・ファーマシューティカルズ・インクはUSFDAからミラベグロン徐放錠USP 25mgおよび50mgの販売承認を取得しました。

COVID-19の大流行は、過活動膀胱治療市場で活動するプレーヤーにとって有利なシナリオをいくつか示しています。米国は北米で大きな影響を受けた国でした。この感染症は、同国の老年人口に深刻な影響を与え、さまざまな合併症を引き起こし、多くの人々の死につながりました。例えば、2022年5月16日現在、米国では84,230,829人のCOVID患者が報告されており、1,026,670人が死亡しています。したがって、過活動膀胱の治療と適切なケアは、慢性的な感染症例や健康状態を防ぐために必要なのです。

COVID-19の発生後、過活動膀胱の発生が増加しています。米国泌尿器科学会の調査によると、COVID-19に感染した患者さんは、過活動膀胱の症状が新たに発生したり、悪化したりするリスクが高くなったそうです。さらに、COVID-19感染者の約3分の1が、感染2ヵ月後に実施した国際失禁質問票過活動膀胱モジュール（ICIQ-OAB）において、臨床症状の著しい増加を報告しています。このうち3分の1、約5人に1人の患者さんが、OABの症状が新たに出現したと報告しています。COVID-19による過活動膀胱の有病率の上昇は、パンデミック時の過活動膀胱治療に対する需要にプラスの影響を与えました。

過活動膀胱治療市場のレポート作成にあたり、世界保健機関（WHO）、疾病対策予防センター（CDC）、米国保健社会福祉省の女性健康局（Office on Women's Health）などの主要一次情報および二次情報を参照しました。

市場促進要因
- 尿失禁の有病率の増加
- 尿路感染症の発生率の増加
主な市場抑制要因
- 治療薬のリコール
主な市場機会
- M&A（合併・買収）の増加
今後の動向
- 強固な医薬品パイプラインと新規治療薬の相次ぐ上市
インパクト分析

第6章過活動膀胱治療の世界市場：世界分析

過活動膀胱治療の世界市場収益と予測・分析
- 過活動膀胱治療の世界市場の収益予測と分析
- 過活動膀胱治療の世界市場- 市場ポテンシャル分析、地域別
- 企業分析
比較企業分析
- 成長戦略分析
- 過活動膀胱治療市場における主要企業の市場ポジショニング
  - アステラス製薬株式会社
  - アラガン・ピーエルシー

第7章過活動膀胱治療市場の分析と2028年までの予測：薬物療法別

過活動膀胱治療の世界市場、薬物療法別2021年・2028年（%）
ミラベグロン
ボトックス
神経刺激
抗コリン剤
膀胱内注入

第8章過活動膀胱治療市場の分析と2028年までの予測：疾患タイプ別

過活動膀胱治療の世界市場：疾患タイプ別2021年・2028年（%）
特発性過活動膀胱
神経因性過活動膀胱

第9章過活動膀胱治療市場の収益と2028年までの予測：地域別分析

北米
- 米国
- カナダ
- メキシコ
欧州
- 英国
- ドイツ
- フランス
- イタリア
- スペイン
- その他欧州
アジア太平洋地域
- 中国
- 日本
- インド
- 韓国
- オーストラリア
- その他アジア太平洋地域
中東・アフリカ地域
- UAE
- サウジアラビア
- 南アフリカ
- その他中東地域
中南米
- アルゼンチン
  - その他の中南米地域

第10章過活動膀胱治療市場へのCOVID-19パンデミックの影響

北米
欧州
アジア太平洋地域
中南米
中東&アフリカ

第11章過活動膀胱治療市場：業界の情勢

市場参加企業が行った成長戦略（%）
有機的な展開

第12章企業プロファイル

Alembic Pharmaceuticals Limited
Astellas Pharma Inc
AbbVie Inc
Teva Pharmaceutical Industries Ltd
Endo Pharmaceuticals Inc.
Hisamitsu Pharmaceutical Co.,Inc.
Medtronic Plc
Colorado Urology Associates, PLLC
Axonics Modulation Technologies, Inc

第13章付録

The Insight Partners について
用語解説

図表

List Of Tables

Table 1. North America: Overactive Bladder Treatment Market, by Pharmacotherapy - Revenue and Forecast to 2028 (US$ Million)
Table 2. North America: Overactive Bladder Treatment Market, by Anticholinergics - Revenue and Forecast to 2028 (US$ Million)
Table 3. North America: Overactive Bladder Treatment Market, by Neurostimulation - Revenue and Forecast to 2028 (US$ Million)
Table 4. North America: Overactive Bladder Treatment Market, by Disease Type - Revenue and Forecast to 2028 (US$ Million)
Table 5. US: Overactive Bladder Treatment Market, by Pharmacotherapy - Revenue and Forecast to 2028 (US$ Million)
Table 6. US: Overactive Bladder Treatment Market, by Anticholinergics - Revenue and Forecast to 2028 (US$ Million)
Table 7. US: Overactive Bladder Treatment Market, by Neurostimulation - Revenue and Forecast to 2028 (US$ Million)
Table 8. US: Overactive Bladder Treatment Market, by Disease Type - Revenue and Forecast to 2028 (US$ Million)
Table 9. Canada: Overactive Bladder Treatment Market, by Pharmacotherapy - Revenue and Forecast to 2028 (US$ Million)
Table 10. Canada: Overactive Bladder Treatment Market, by Anticholinergics - Revenue and Forecast to 2028 (US$ Million)
Table 11. Canada: Overactive Bladder Treatment Market, by Neurostimulation - Revenue and Forecast to 2028 (US$ Million)
Table 12. Canada: Overactive Bladder Treatment Market, by Disease Type - Revenue and Forecast to 2028 (US$ Million)
Table 13. Mexico: Overactive Bladder Treatment Market, by Pharmacotherapy - Revenue and Forecast to 2028 (US$ Million)
Table 14. Mexico: Overactive Bladder Treatment Market, by Anticholinergics - Revenue and Forecast to 2028 (US$ Million)
Table 15. Mexico: Overactive Bladder Treatment Market, by Neurostimulation - Revenue and Forecast to 2028 (US$ Million)
Table 16. Mexico: Overactive Bladder Treatment Market, by Disease Type - Revenue and Forecast to 2028 (US$ Million)
Table 17. Europe: Overactive Bladder Treatment Market, by Pharmacotherapy - Revenue and Forecast to 2028 (US$ Million)
Table 18. Europe: Overactive Bladder Treatment Market, by Anticholinergics - Revenue and Forecast to 2028 (US$ Million)
Table 19. Europe: Overactive Bladder Treatment Market, by Neurostimulation - Revenue and Forecast to 2028 (US$ Million)
Table 20. Europe: Overactive Bladder Treatment Market, by Disease Type - Revenue and Forecast to 2028 (US$ Million)
Table 21. UK: Overactive Bladder Treatment Market, by Pharmacotherapy - Revenue and Forecast to 2028 (US$ Million)
Table 22. UK: Overactive Bladder Treatment Market, by Anticholinergics - Revenue and Forecast to 2028 (US$ Million)
Table 23. UK: Overactive Bladder Treatment Market, by Neurostimulation - Revenue and Forecast to 2028 (US$ Million)
Table 24. UK: Overactive Bladder Treatment Market, by Disease Type - Revenue and Forecast to 2028 (US$ Million)
Table 25. Germany: Overactive Bladder Treatment Market, by Pharmacotherapy - Revenue and Forecast to 2028 (US$ Million)
Table 26. Germany: Overactive Bladder Treatment Market, by Anticholinergics - Revenue and Forecast to 2028 (US$ Million)
Table 27. Germany: Overactive Bladder Treatment Market, by Neurostimulation - Revenue and Forecast to 2028 (US$ Million)
Table 28. Germany: Overactive Bladder Treatment Market, by Disease Type - Revenue and Forecast to 2028 (US$ Million)
Table 29. France: Overactive Bladder Treatment Market, by Pharmacotherapy - Revenue and Forecast to 2028 (US$ Million)
Table 30. France: Overactive Bladder Treatment Market, by Anticholinergics - Revenue and Forecast to 2028 (US$ Million)
Table 31. France: Overactive Bladder Treatment Market, by Neurostimulation - Revenue and Forecast to 2028 (US$ Million)
Table 32. France: Overactive Bladder Treatment Market, by Disease Type - Revenue and Forecast to 2028 (US$ Million)
Table 33. Italy: Overactive Bladder Treatment Market, by Pharmacotherapy - Revenue and Forecast to 2028 (US$ Million)
Table 34. Italy: Overactive Bladder Treatment Market, by Anticholinergics - Revenue and Forecast to 2028 (US$ Million)
Table 35. Italy: Overactive Bladder Treatment Market, by Neurostimulation - Revenue and Forecast to 2028 (US$ Million)
Table 36. Italy: Overactive Bladder Treatment Market, by Disease Type - Revenue and Forecast to 2028 (US$ Million)
Table 37. Spain: Overactive Bladder Treatment Market, by Pharmacotherapy - Revenue and Forecast to 2028 (US$ Million)
Table 38. Spain: Overactive Bladder Treatment Market, by Anticholinergics - Revenue and Forecast to 2028 (US$ Million)
Table 39. Spain: Overactive Bladder Treatment Market, by Neurostimulation - Revenue and Forecast to 2028 (US$ Million)
Table 40. Spain: Overactive Bladder Treatment Market, by Disease Type - Revenue and Forecast to 2028 (US$ Million)
Table 41. Rest of Europe: Overactive Bladder Treatment Market, by Pharmacotherapy - Revenue and Forecast to 2028 (US$ Million)
Table 42. Rest of Europe: Overactive Bladder Treatment Market, by Anticholinergics - Revenue and Forecast to 2028 (US$ Million)
Table 43. Rest of Europe: Overactive Bladder Treatment Market, by Neurostimulation - Revenue and Forecast to 2028 (US$ Million)
Table 44. Rest of Europe: Overactive Bladder Treatment Market, by Disease Type - Revenue and Forecast to 2028 (US$ Million)
Table 45. Asia Pacific Overactive Bladder Treatment Market, by Pharmacotherapy - Revenue and Forecast to 2028 (US$ Million)
Table 46. Asia Pacific Overactive Bladder Treatment Market, by Anticholinergic - Revenue and Forecast to 2028 (US$ Million)
Table 47. Asia Pacific Overactive Bladder Treatment Market, by Neurostimulation - Revenue and Forecast to 2028 (US$ Million)
Table 48. Asia Pacific Overactive Bladder Treatment Market, by Disease Type - Revenue and Forecast to 2028 (US$ Million)
Table 49. China Overactive Bladder Treatment Market, by Pharmacotherapy - Revenue and Forecast to 2028 (US$ Million)
Table 50. China Overactive Bladder Treatment Market, by Anticholinergic - Revenue and Forecast to 2028 (US$ Million)
Table 51. China Overactive Bladder Treatment Market, by Neurostimulation - Revenue and Forecast to 2028 (US$ Million)
Table 52. China Overactive Bladder Treatment Market, by Disease Type - Revenue and Forecast to 2028 (US$ Million)
Table 53. Japan Overactive Bladder Treatment Market, by Pharmacotherapy - Revenue and Forecast to 2028 (US$ Million)
Table 54. Japan Overactive Bladder Treatment Market, by Anticholinergic - Revenue and Forecast to 2028 (US$ Million)
Table 55. Japan Overactive Bladder Treatment Market, by Neurostimulation - Revenue and Forecast to 2028 (US$ Million)
Table 56. Japan Overactive Bladder Treatment Market, by Disease Type - Revenue and Forecast to 2028 (US$ Million)
Table 57. India Overactive Bladder Treatment Market, by Pharmacotherapy - Revenue and Forecast to 2028 (US$ Million)
Table 58. India Overactive Bladder Treatment Market, by Anticholinergic - Revenue and Forecast to 2028 (US$ Million)
Table 59. India Overactive Bladder Treatment Market, by Neurostimulation - Revenue and Forecast to 2028 (US$ Million)
Table 60. India Overactive Bladder Treatment Market, by Disease Type - Revenue and Forecast to 2028 (US$ Million)
Table 61. South Korea Overactive Bladder Treatment Market, by Pharmacotherapy - Revenue and Forecast to 2028 (US$ Million)
Table 62. South Korea Overactive Bladder Treatment Market, by Anticholinergic - Revenue and Forecast to 2028 (US$ Million)
Table 63. South Korea Overactive Bladder Treatment Market, by Neurostimulation - Revenue and Forecast to 2028 (US$ Million)
Table 64. South Korea Overactive Bladder Treatment Market, by Disease Type - Revenue and Forecast to 2028 (US$ Million)
Table 65. Australia Overactive Bladder Treatment Market, by Pharmacotherapy - Revenue and Forecast to 2028 (US$ Million)
Table 66. Australia Overactive Bladder Treatment Market, by Anticholinergic - Revenue and Forecast to 2028 (US$ Million)
Table 67. Australia Overactive Bladder Treatment Market, by Neurostimulation - Revenue and Forecast to 2028 (US$ Million)
Table 68. Australia Overactive Bladder Treatment Market, by Disease Type - Revenue and Forecast to 2028 (US$ Million)
Table 69. Rest of Asia Pacific Overactive Bladder Treatment Market, by Pharmacotherapy - Revenue and Forecast to 2028 (US$ Million)
Table 70. Rest of Asia Pacific Overactive Bladder Treatment Market, by Anticholinergic - Revenue and Forecast to 2028 (US$ Million)
Table 71. Rest of Asia Pacific Overactive Bladder Treatment Market, by Neurostimulation - Revenue and Forecast to 2028 (US$ Million)
Table 72. Rest of Asia Pacific Overactive Bladder Treatment Market, by Disease Type - Revenue and Forecast to 2028 (US$ Million)
Table 73. Middle East & Africa Overactive Bladder Treatment Market, by Pharmacotherapy - Revenue and Forecast to 2028 (US$ Million)
Table 74. Middle East & Africa Overactive Bladder Treatment Market, by Anticholinergic - Revenue and Forecast to 2028 (US$ Million)
Table 75. Middle East & Africa Overactive Bladder Treatment Market, by Neurostimulation - Revenue and Forecast to 2028 (US$ Million)
Table 76. Middle East & Africa Overactive Bladder Treatment Market, by Disease Type - Revenue and Forecast to 2028 (US$ Million)
Table 77. UAE Overactive Bladder Treatment Market, by Pharmacotherapy - Revenue and Forecast to 2028 (US$ Million)
Table 78. UAE Overactive Bladder Treatment Market, by Anticholinergic - Revenue and Forecast to 2028 (US$ Million)
Table 79. UAE Overactive Bladder Treatment Market, by Neurostimulation - Revenue and Forecast to 2028 (US$ Million)
Table 80. UAE Overactive Bladder Treatment Market, by Disease Type - Revenue and Forecast to 2028 (US$ Million)
Table 81. Saudi Arabia Overactive Bladder Treatment Market, by Pharmacotherapy - Revenue and Forecast to 2028 (US$ Million)
Table 82. Saudi Arabia Overactive Bladder Treatment Market, by Anticholinergic - Revenue and Forecast to 2028 (US$ Million)
Table 83. Saudi Arabia Overactive Bladder Treatment Market, by Neurostimulation - Revenue and Forecast to 2028 (US$ Million)
Table 84. Saudi Arabia Overactive Bladder Treatment Market, by Disease Type - Revenue and Forecast to 2028 (US$ Million)
Table 85. South Africa Overactive Bladder Treatment Market, by Pharmacotherapy - Revenue and Forecast to 2028 (US$ Million)
Table 86. South Africa Overactive Bladder Treatment Market, by Anticholinergic - Revenue and Forecast to 2028 (US$ Million)
Table 87. South Africa Overactive Bladder Treatment Market, by Neurostimulation - Revenue and Forecast to 2028 (US$ Million)
Table 88. South Africa Overactive Bladder Treatment Market, by Disease Type - Revenue and Forecast to 2028 (US$ Million)
Table 89. Rest of Middle East & Africa Overactive Bladder Treatment Market, by Pharmacotherapy - Revenue and Forecast to 2028 (US$ Million)
Table 90. Rest of Middle East & Africa Overactive Bladder Treatment Market, by Anticholinergic - Revenue and Forecast to 2028 (US$ Million)
Table 91. Rest of Middle East & Africa Overactive Bladder Treatment Market, by Neurostimulation - Revenue and Forecast to 2028 (US$ Million)
Table 92. Rest of Middle East & Africa Overactive Bladder Treatment Market, by Disease Type - Revenue and Forecast to 2028 (US$ Million)
Table 93. South and Central America Overactive Bladder Treatment Market, by Pharmacotherapy- Revenue and Forecast to 2028 (USD Million)
Table 94. South and Central America Overactive Bladder Treatment Market, by Anticholinergic - Revenue and Forecast to 2028 (US$ Million)
Table 95. South and Central America Overactive Bladder Treatment Market, by Neurostimulation - Revenue and Forecast to 2028 (US$ Million)
Table 96. South and Central America Overactive Bladder Treatment Market, by Disease Type- Revenue and Forecast to 2028 (USD Million)
Table 97. Brazil Overactive Bladder Treatment Market, by Pharmacotherapy - Revenue and Forecast to 2028 (USD Million)
Table 98. Brazil Overactive Bladder Treatment Market, by Anticholinergic - Revenue and Forecast to 2028 (US$ Million)
Table 99. Brazil Overactive Bladder Treatment Market, by Neurostimulation - Revenue and Forecast to 2028 (US$ Million)
Table 100. Brazil Overactive Bladder Treatment Market, by Disease Type - Revenue and Forecast to 2028 (USD Million)
Table 101. Argentina Overactive Bladder Treatment Market, by Pharmacotherapy - Revenue and Forecast to 2028 (USD Million)
Table 102. Argentina Overactive Bladder Treatment Market, by Anticholinergic - Revenue and Forecast to 2028 (US$ Million)
Table 103. Argentina Overactive Bladder Treatment Market, by Neurostimulation - Revenue and Forecast to 2028 (US$ Million)
Table 104. Argentina Overactive Bladder Treatment Market, by Disease Type - Revenue and Forecast to 2028 (USD Million)
Table 105. Rest of South and Central America Overactive Bladder Treatment Market, by Pharmacotherapy - Revenue and Forecast to 2028 (USD Million)
Table 106. Rest of South and Central America Overactive Bladder Treatment Market, by Anticholinergic - Revenue and Forecast to 2028 (US$ Million)
Table 107. Rest of South and Central America Overactive Bladder Treatment Market, by Neurostimulation - Revenue and Forecast to 2028 (US$ Million)
Table 108. Rest of South and Central America Overactive Bladder Treatment Market, by Disease Type - Revenue and Forecast to 2028 (USD Million)
Table 109. Organic Developments Done by Companies
Table 110. Glossary of Terms

List Of Figures

Figure 1. Global Overactive Bladder Treatment Market Segmentation
Figure 2. Global Overactive Bladder Treatment Market Segmentation, By Region
Figure 3. Global Overactive Bladder Treatment Market Overview
Figure 4. Mirabegron Segment Held Largest Share by Pharmacotherapy in Overactive Bladder Treatment market
Figure 5. Asia-Pacific Region Is Expected to Show Remarkable Growth During the Forecast Period
Figure 6. Global Overactive Bladder Treatment Market, By Geography (US$ Million)
Figure 7. Global Overactive Bladder Treatment Market - Leading Country Markets (US$ Million)
Figure 8. Global Overactive Bladder Treatment Market, Industry Landscape
Figure 9. North America: PEST Analysis
Figure 10. Europe: PEST Analysis
Figure 11. Asia Pacific: PEST Analysis
Figure 12. South & Central America: PEST Analysis
Figure 13. Middle East & Africa: PEST Analysis
Figure 14. Overactive Bladder Treatment Market: Impact Analysis of Driver and Restraints
Figure 15. Global Overactive Bladder Treatment Market - Revenue Forecast and Analysis - 2020- 2028
Figure 16. Global Overactive Bladder Treatment Market - Revenue Forecast and Analysis - 2021- 2028
Figure 17. Global Overactive Bladder Treatment Market - Market Potential Analysis, By Region
Figure 18. Analysis of Key Players in Overactive Bladder Treatment Market
Figure 19. Global Overactive Bladder Treatment Market - Comparative Company Analysis
Figure 20. Global Overactive Bladder Treatment Market - Growth Strategy Analysis
Figure 21. Global Overactive Bladder Treatment Market, by Pharmacotherapy 2021 & 2028 (%)
Figure 22. Mirabegron Market Revenue and Forecasts to 2028 (US$ Million)
Figure 23. Botox Market Revenue and Forecasts to 2028 (US$ Million)
Figure 24. Neurostimulation Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 25. Transcutaneous Sacral Nerve Stimulation Market Revenue and Forecasts To 2028 (US$ MN)
Figure 26. Transcutaneous Tibial Nerve Stimulation Market Revenue and Forecasts To 2028 (US$ MN)
Figure 27. Percutaneous Posterior Tibial Nerve Stimulation Market Revenue and Forecasts To 2028 (US$ MN)
Figure 28. Others Market Revenue and Forecasts To 2028 (US$ MN)
Figure 29. Anticholinergics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 30. Solifenacin Market Revenue and Forecasts To 2028 (US$ Million)
Figure 31. Oxybutynin Market Revenue and Forecasts To 2028 (US$ Million)
Figure 32. Fesoterodine Market Revenue and Forecasts To 2028 (US$ Million)
Figure 33. Darifenacin Market Revenue and Forecasts To 2028 (US$ Million)
Figure 34. Tolterodine Market Revenue and Forecasts To 2028 (US$ Million)
Figure 35. Trospium Market Revenue and Forecasts To 2028 (US$ Million)
Figure 36. Other Anticholinergics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 37. Intravesical Instillation Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 38. Global Overactive Bladder Treatment Market, by Disease Type 2021 & 2028 (%)
Figure 39. Idiopathic Overactive Bladder Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 40. Neurogenic Overactive Bladder Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 41. North America: Overactive Bladder Treatment Market Revenue Overview, By Key Country - Revenue (2021) (US$ Million)
Figure 42. North America: Overactive Bladder Treatment Market Revenue and Forecast To 2028 (US$ Million)
Figure 43. North America: Overactive Bladder Treatment Market, By Country, 2021 & 2028 (%)
Figure 44. US: Overactive Bladder Treatment Market Revenue and Forecast To 2028 (US$ Million)
Figure 45. Canada: Overactive Bladder Treatment Market Revenue and Forecast To 2028 (US$ Million)
Figure 46. Mexico: Overactive Bladder Treatment Market Revenue and Forecast To 2028 (US$ Million)
Figure 47. Europe: Overactive Bladder Treatment Market, by Key Country - Revenue (2021) (US$ Million)
Figure 48. Europe: Overactive Bladder Treatment Market Revenue and Forecast to 2028 (US$ Million)
Figure 49. Europe: Overactive Bladder Treatment Market, by Country, 2021 & 2028 (%)
Figure 50. UK: Overactive Bladder Treatment Market - Revenue and Forecast to 2028 (US$ Million)
Figure 51. Germany: Overactive Bladder Treatment Market - Revenue and Forecast to 2028 (US$ Million)
Figure 52. France: Overactive Bladder Treatment Market - Revenue and Forecast to 2028 (US$ Million)
Figure 53. Italy: Overactive Bladder Treatment Market - Revenue and Forecast to 2028 (US$ Million)
Figure 54. Spain: Overactive Bladder Treatment Market - Revenue and Forecast to 2028 (US$ Million)
Figure 55. Rest of Europe: Overactive Bladder Treatment Market - Revenue and Forecast to 2028 (US$ Million)
Figure 56. Asia Pacific: Overactive Bladder Treatment Market, by Key Country - Revenue (2021) (US$ Million)
Figure 57. Asia Pacific Overactive Bladder Treatment Market Revenue and Forecast to 2028 (USD Million)
Figure 58. China: Overactive Bladder Treatment Market - Revenue and Forecast to 2028 (US$ Million)
Figure 59. Japan: Overactive Bladder Treatment Market - Revenue and Forecast to 2028 (US$ Million)
Figure 60. India: Overactive Bladder Treatment Market - Revenue and Forecast to 2028 (US$ Million)
Figure 61. South Korea: Overactive Bladder Treatment Market - Revenue and Forecast to 2028 (US$ Million)
Figure 62. Australia: Overactive Bladder Treatment Market - Revenue and Forecast to 2028 (US$ Million)
Figure 63. Rest of Asia Pacific: Overactive Bladder Treatment Market - Revenue and Forecast to 2028 (US$ Million)
Figure 64. Middle East & Africa: Overactive Bladder Treatment Market, by Key Country - Revenue (2021) (US$ Million)
Figure 65. Middle East & Africa Overactive Bladder Treatment Market Revenue and Forecast to 2028 (USD Million)
Figure 66. UAE: Overactive Bladder Treatment Market - Revenue and Forecast to 2028 (US$ Million)
Figure 67. Saudi Arabia: Overactive Bladder Treatment Market - Revenue and Forecast to 2028 (US$ Million)
Figure 68. South Africa: Overactive Bladder Treatment Market - Revenue and Forecast to 2028 (US$ Million)
Figure 69. Rest of Middle East & Africa: Overactive Bladder Treatment Market - Revenue and Forecast to 2028 (US$ Million)
Figure 70. South and Central America: Overactive Bladder Treatment Market, by Key Country - Revenue (2021) (USD Million)
Figure 71. South and Central America Overactive Bladder Treatment Market Revenue and Forecast to 2028 (USD Million)
Figure 72. Brazil: Overactive Bladder Treatment Market - Revenue and Forecast to 2028 (USD Million)
Figure 73. Argentina: Overactive Bladder Treatment Market - Revenue and Forecast to 2028 (USD Million)
Figure 74. Rest of South and Central America: Overactive Bladder Treatment Market - Revenue and Forecast to 2028 (USD Million)
Figure 75. Impact of COVID-19 Pandemic on North American Country Markets
Figure 76. Impact of COVID-19 Pandemic in European Countries Markets
Figure 77. Impact of COVID-19 Pandemic in Asia-Pacific Country Markets
Figure 78. Impact of COVID-19 Pandemic on South and Central America Country Markets
Figure 79. Impact of COVID-19 Pandemic in Middle East & Africa Country Markets
Figure 80. Growth Strategies Done by the Companies in the Market, (%)

Product Code: TIPRE00004082

The global overactive bladder treatment market is expected to grow from US$ 4,295.93 million in 2021 to US$ 5,333.92 million by 2028. It is estimated to grow at a CAGR of 3.1% from 2022 to 2028.

Overactive bladder (OAB) is the frequent and sudden urge to urinate, which might be difficult to control. OAB can be caused due to abdominal trauma, infection, nerve damage, and certain medications. OAB is common in people aged 65 and older. Women may have OAB after 45 years. The treatment includes changing certain behaviors, medications, and nerve stimulation. According to the National Association for Incontinence data, in 2018, ~200 million people worldwide were affected by urinary incontinence. Stress incontinence and urge incontinence are the two common types of urinary incontinence affecting women, wherein the latter is also known as overactive bladder.

Similarly, a study conducted by a group of researchers at the American College of Physicians and Infectious Diseases Society of America in 2020 stated that urinary tract infection (UTI) was the cause of ~6 million physician visits each year in the US. In Canada, ~500,000 visits to the doctor's office are for UTI consultations annually. UTI is the eighth and fifth most common reason for ambulatory clinic visits and emergency department visits, respectively, in the country. Thus, increasing prevalence of urinary incontinence and growing incidence of urinary tract infections are driving the overactive bladder treatment market.

The overactive bladder treatment market is segmented into pharmacotherapy, disease type, and geography. By geography, the market is broadly segmented into North America, Europe, Asia Pacific, the Middle East & Africa, and South & Central America. The overactive bladder treatment market report offers insights and in-depth analysis of the market, emphasizing parameters, such as market trends, market dynamics, and the competitive analysis of the globally leading market players.

Based on pharmacotherapy, the overactive bladder treatment market is segmented into mirabegron, Botox, neurostimulation, anticholinergics, and intravesical instillation. The mirabegron segment held the largest share of the market in 2021 and is anticipated to register the highest CAGR during the forecast period. Mirabegron is used alone or with solifenacin to treat overactive bladder in adults. It is used to treat neurogenic detrusor overactivity (a bladder control condition caused by the brain, spinal cord, or nerve problem) in children aged three years or more. Mirabegron belongs to the class of drugs called beta-3 adrenergic agonists. It relaxes the bladder muscles to prevent urgent, frequent, or uncontrolled urination. Mirabegron is available as an extended-release (long-acting) tablet and an extended-release suspension that can be taken orally. In October 2022, Zydus Pharmaceuticals Inc. received approval from the USFDA to market Mirabegron Extended-Release Tablets USP 25 mg and 50 mg.

The COVID-19 pandemic has shown some favorable scenarios for players operating in the overactive bladder treatment market. The US was the highly affected country in North America. The infection severely affected the geriatric population in the country, causing various complications and leading to the death of a large population. For instance, as of May 16, 2022, the US reported 84,230,829 COVID cases with 1,026,670 deaths. Therefore, overactive bladder treatment and proper care are required to prevent chronic cases of infection and health conditions.

After the COVID-19 outbreak, there has been an increase in the occurrence of OAB. According to a study by American Urological Association, patients with COVID-19 infections were at an increased risk for developing new or worsening overactive bladder symptoms. Moreover, approximately one-third of patients with COVID-19 reported a significant increase in clinical symptoms during the International Consultation on Incontinence Questionnaire Overactive Bladder Module (ICIQ-OAB) conducted two months after infection. Out of these one-third of patients, approximately 1 in 5 patients, reported that their OAB symptoms were new. This increased prevalence of OAB due to COVID-19 positively impacted the demand for overactive bladder treatment during the pandemic.

Some of the key primary and secondary sources referred to while preparing the report on the overactive bladder treatment market are the World Health Organization (WHO), the Centers for Disease Control and Prevention (CDC), and the Office on Women's Health-a division of US Department of Health and Human Services, among others.

Reasons to Buy:

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the overactive bladder treatment market.

Highlights key business priorities in order to assist companies to realign their business strategies.

The key findings and recommendations highlight crucial progressive industry trends in the global overactive bladder treatment market, thereby allowing players across the value chain to develop effective long-term strategies.

Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.

Scrutinize in-depth global market trends and outlook coupled with the factors driving the overactive bladder treatment market, as well as those hindering it.

Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing, and distribution.

1. Introduction

1.1 Study Scope
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
- 1.3.1 Global Overactive Bladder Treatment Market- By Pharmacotherapy
- 1.3.2 Global Overactive Bladder Treatment Market- By Disease Type
- 1.3.3 Global Overactive Bladder Treatment Market - By Geography

2. Global Overactive Bladder Treatment Market - Key Takeaways

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. Global Overactive Bladder Treatment Market - Market Landscape

4.1 Overview
4.2 PEST Analysis
- 4.2.1 North America - PEST Analysis
- 4.2.2 Europe - PEST Analysis
- 4.2.3 Asia Pacific - PEST Analysis
- 4.2.4 South & Central America - PEST Analysis
- 4.2.5 Middle East & Africa - PEST Analysis
4.3 Expert Opinion

5. Overactive Bladder Treatment Market - Key Market Dynamics

5.1 Market Drivers
- 5.1.1 Increase in Prevalence of Urinary Incontinence
- 5.1.2 Growing Incidence of Urinary Tract Infections
5.2 Key Market Restraints
- 5.2.1 Recalls of Therapeutic Drugs
5.3 Key Market Opportunities
- 5.3.1 Increasing Number of Mergers and Acquisitions
5.4 Future Trends
- 5.4.1 Robust Pipeline of Drugs and Successive Launch of Novel Therapies
5.5 Impact analysis

6. Global Overactive Bladder Treatment Market - Global Analysis

6.1 Global Overactive Bladder Treatment Market Revenue Forecast and Analysis
- 6.1.1 Global Overactive Bladder Treatment Market Revenue Forecast and Analysis
- 6.1.2 Global Overactive Bladder Treatment Market - Market Potential Analysis, By Region
- 6.1.3 Company Analysis
6.2 Comparative Company Analysis
- 6.2.1 Growth Strategy Analysis
- 6.2.2 Market Positioning of Key Players in the Overactive Bladder Treatment Market
  - 6.2.2.1 Astellas Pharma Inc.
  - 6.2.2.2 Allergan Plc

7. Overactive Bladder Treatment Market Analysis and Forecasts To 2028 - By Pharmacotherapy

7.1 Overview
7.2 Global Overactive Bladder Treatment Market, By Pharmacotherapy 2021 & 2028 (%)
7.3 Mirabegron
- 7.3.1 Overview
- 7.3.2 Mirabegron Market Revenue and Forecast to 2028 (US$ Million)
7.4 Botox
- 7.4.1 Overview
- 7.4.2 Botox Market Revenue and Forecast to 2028 (US$ Million)
7.5 Neurostimulation
- 7.5.1 Overview
- 7.5.2 Neurostimulation Market Revenue and Forecast to 2028 (US$ Mn)
- 7.5.3 Transcutaneous Sacral Nerve Stimulation
  - 7.5.3.1 Overview
  - 7.5.3.2 Transcutaneous Sacral Nerve Stimulation Market Revenue and Forecast to 2028 (US$ Mn)
- 7.5.4 Transcutaneous Tibial Nerve Stimulation
  - 7.5.4.1 Overview
  - 7.5.4.2 Transcutaneous Tibial Nerve Stimulation Market Revenue and Forecast to 2028 (US$ Mn)
- 7.5.5 Percutaneous Posterior Tibial Nerve Stimulation
  - 7.5.5.1 Overview
  - 7.5.5.2 Percutaneous Posterior Tibial Nerve Stimulation Market Revenue and Forecast to 2028 (US$ Mn)
- 7.5.6 Others
  - 7.5.6.1 Overview
  - 7.5.6.2 Others Market Revenue and Forecast to 2028 (US$ Mn)
7.6 Anticholinergics
- 7.6.1 Overview
- 7.6.2 Anticholinergics Market Revenue and Forecast to 2028 (US$ Million)
- 7.6.3 Solifenacin
  - 7.6.3.1 Overview
  - 7.6.3.2 Solifenacin Market Revenue and Forecast to 2028 (US$ Million)
- 7.6.4 Oxybutynin
  - 7.6.4.1 Overview
  - 7.6.4.2 Oxybutynin Market Revenue and Forecast to 2028 (US$ Million)
- 7.6.5 Fesoterodine
  - 7.6.5.1 Overview
  - 7.6.5.2 Fesoterodine Market Revenue and Forecast to 2028 (US$ Million)
- 7.6.6 Darifenacin
  - 7.6.6.1 Overview
  - 7.6.6.2 Darifenacin Market Revenue and Forecast to 2028 (US$ Million)
- 7.6.7 Tolterodine
  - 7.6.7.1 Overview
  - 7.6.7.2 Tolterodine Market Revenue and Forecast to 2028 (US$ Million)
- 7.6.8 Trospium
  - 7.6.8.1 Overview
  - 7.6.8.2 Trospium Market Revenue and Forecast to 2028 (US$ Million)
- 7.6.9 Other Anticholinergics
  - 7.6.9.1 Overview
  - 7.6.9.2 Other Anticholinergics Market Revenue and Forecast to 2028 (US$ Million)
7.7 Intravesical Instillation
- 7.7.1 Overview
- 7.7.2 Intravesical Instillation Market Revenue and Forecast to 2028 (US$ Mn)

8. Overactive Bladder Treatment Market Analysis and Forecasts To 2028 - By Disease Type

8.1 Overview
8.2 Global Overactive Bladder Treatment Market, By Disease Type 2021 & 2028 (%)
8.3 Idiopathic Overactive Bladder
- 8.3.1 Overview
- 8.3.2 Idiopathic Overactive Bladder Market Revenue and Forecast to 2028 (US$ Mn)
8.4 Neurogenic Overactive Bladder
- 8.4.1 Overview
- 8.4.2 Neurogenic Overactive Bladder Market Revenue and Forecast to 2028 (US$ Mn)

9. Overactive Bladder Treatment Market Revenue and Forecasts to 2028 - Geographical Analysis

9.1 North America: Overactive Bladder Treatment Market
- 9.1.1 Overview
- 9.1.2 North America: Overactive Bladder Treatment Market Revenue and Forecast to 2028 (US$ Million)
- 9.1.3 North America: Overactive Bladder Treatment Market, by Pharmacotherapy - Revenue and Forecast to 2028 (US$ Million)
  - 9.1.3.1 North America: Overactive Bladder Treatment Market, by Anticholinergics- Revenue and Forecast to 2028 (US$ Million)
  - 9.1.3.2 North America: Overactive Bladder Treatment Market, by Neurostimulation- Revenue and Forecast to 2028 (US$ Million)
- 9.1.4 North America: Overactive Bladder Treatment Market, by Disease Type- Revenue and Forecast to 2028 (US$ Million)
- 9.1.5 North America: Overactive Bladder Treatment Market, by Country, 2021 & 2028 (%)
  - 9.1.5.1 US: Overactive Bladder Treatment Market - Revenue and Forecast to 2028 (US$ Million)
    - 9.1.5.1.1 US: Overactive Bladder Treatment Market Revenue and Forecast to 2028 (US$ Million)
    - 9.1.5.1.2 US: Overactive Bladder Treatment Market, by Pharmacotherapy - Revenue and Forecast to 2028 (US$ Million)
    - 9.1.5.1.2.1 US: Overactive Bladder Treatment Market, by Anticholinergics- Revenue and Forecast to 2028 (US$ Million)
    - 9.1.5.1.2.2 US: Overactive Bladder Treatment Market, by Neurostimulation- Revenue and Forecast to 2028 (US$ Million)
    - 9.1.5.1.3 US: Overactive Bladder Treatment Market, by Disease Type- Revenue and Forecast to 2028 (US$ Million)
  - 9.1.5.2 Canada: Overactive Bladder Treatment Market - Revenue and Forecast to 2028 (US$ Million)
    - 9.1.5.2.1 Canada: Overactive Bladder Treatment Market Revenue and Forecast to 2028 (US$ Million)
    - 9.1.5.2.2 Canada: Overactive Bladder Treatment Market, by Pharmacotherapy - Revenue and Forecast to 2028 (US$ Million)
    - 9.1.5.2.2.1 Canada: Overactive Bladder Treatment Market, by Anticholinergics - Revenue and Forecast to 2028 (US$ Million)
    - 9.1.5.2.2.2 Canada: Overactive Bladder Treatment Market, by Neurostimulation- Revenue and Forecast to 2028 (US$ Million)
    - 9.1.5.2.3 Canada: Overactive Bladder Treatment Market, by Disease Type- Revenue and Forecast to 2028 (US$ Million)
  - 9.1.5.3 Mexico: Overactive Bladder Treatment Market - Revenue and Forecast to 2028 (US$ Million)
    - 9.1.5.3.1 Mexico: Overactive Bladder Treatment Market Revenue and Forecast to 2028 (US$ Million)
    - 9.1.5.3.2 Mexico: Overactive Bladder Treatment Market, by Pharmacotherapy - Revenue and Forecast to 2028 (US$ Million)
    - 9.1.5.3.2.1 Mexico: Overactive Bladder Treatment Market, by Anticholinergics - Revenue and Forecast to 2028 (US$ Million)
    - 9.1.5.3.2.2 Mexico: Overactive Bladder Treatment Market, by Neurostimulation- Revenue and Forecast to 2028 (US$ Million)
    - 9.1.5.3.3 Mexico: Overactive Bladder Treatment Market, by Disease Type- Revenue and Forecast to 2028 (US$ Million)
9.2 Europe: Overactive Bladder Treatment Market
- 9.2.1 Overview
- 9.2.2 Europe: Overactive Bladder Treatment Market - Revenue and Forecast to 2028 (US$ Million)
- 9.2.3 Europe: Overactive Bladder Treatment Market, by Pharmacotherapy - Revenue and Forecast to 2028 (US$ Million)
  - 9.2.3.1 Europe: Overactive Bladder Treatment Market, by Anticholinergics - Revenue and Forecast to 2028 (US$ Million)
  - 9.2.3.2 Europe: Overactive Bladder Treatment Market, by Neurostimulation - Revenue and Forecast to 2028 (US$ Million)
- 9.2.4 Europe: Overactive Bladder Treatment Market, by Disease Type - Revenue and Forecast to 2028 (US$ Million)
- 9.2.5 Europe: Overactive Bladder Treatment Market, by Country, 2021 & 2028 (%)
  - 9.2.5.1 UK: Overactive Bladder Treatment Market - Revenue and Forecast to 2028 (US$ Million)
    - 9.2.5.1.1 UK: Overactive Bladder Treatment Market - Revenue and Forecast to 2028 (US$ Million)
    - 9.2.5.1.2 UK: Overactive Bladder Treatment Market, by Pharmacotherapy - Revenue and Forecast to 2028 (US$ Million)
    - 9.2.5.1.2.1 UK: Overactive Bladder Treatment Market, by Anticholinergics - Revenue and Forecast to 2028 (US$ Million)
    - 9.2.5.1.2.2 UK: Overactive Bladder Treatment Market, by Neurostimulation - Revenue and Forecast to 2028 (US$ Million)
    - 9.2.5.1.3 UK: Overactive Bladder Treatment Market, by Disease Type - Revenue and Forecast to 2028 (US$ Million)
  - 9.2.5.2 Germany: Overactive Bladder Treatment Market - Revenue and Forecast to 2028 (US$ Million)
    - 9.2.5.2.1 Germany: Overactive Bladder Treatment Market - Revenue and Forecast to 2028 (US$ Million)
    - 9.2.5.2.2 Germany: Overactive Bladder Treatment Market, by Pharmacotherapy - Revenue and Forecast to 2028 (US$ Million)
    - 9.2.5.2.2.1 Germany: Overactive Bladder Treatment Market, by Anticholinergics - Revenue and Forecast to 2028 (US$ Million)
    - 9.2.5.2.2.2 Germany: Overactive Bladder Treatment Market, by Neurostimulation - Revenue and Forecast to 2028 (US$ Million)
    - 9.2.5.2.3 Germany: Overactive Bladder Treatment Market, by Disease Type - Revenue and Forecast to 2028 (US$ Million)
  - 9.2.5.3 France: Overactive Bladder Treatment Market - Revenue and Forecast to 2028 (US$ Million)
    - 9.2.5.3.1 France: Overactive Bladder Treatment Market - Revenue and Forecast to 2028 (US$ Million)
    - 9.2.5.3.2 France: Overactive Bladder Treatment Market, by Pharmacotherapy - Revenue and Forecast to 2028 (US$ Million)
    - 9.2.5.3.2.1 France: Overactive Bladder Treatment Market, by Anticholinergics - Revenue and Forecast to 2028 (US$ Million)
    - 9.2.5.3.2.2 France: Overactive Bladder Treatment Market, by Neurostimulation - Revenue and Forecast to 2028 (US$ Million)
    - 9.2.5.3.3 France: Overactive Bladder Treatment Market, by Disease Type - Revenue and Forecast to 2028 (US$ Million)
  - 9.2.5.4 Italy: Overactive Bladder Treatment Market - Revenue and Forecast to 2028 (US$ Million)
    - 9.2.5.4.1 Italy: Overactive Bladder Treatment Market - Revenue and Forecast to 2028 (US$ Million)
    - 9.2.5.4.2 Italy: Overactive Bladder Treatment Market, by Pharmacotherapy - Revenue and Forecast to 2028 (US$ Million)
    - 9.2.5.4.2.1 Italy: Overactive Bladder Treatment Market, by Anticholinergics - Revenue and Forecast to 2028 (US$ Million)
    - 9.2.5.4.2.2 Italy: Overactive Bladder Treatment Market, by Neurostimulation - Revenue and Forecast to 2028 (US$ Million)
    - 9.2.5.4.3 Italy: Overactive Bladder Treatment Market, by Disease Type - Revenue and Forecast to 2028 (US$ Million)
  - 9.2.5.5 Spain: Overactive Bladder Treatment Market - Revenue and Forecast to 2028 (US$ Million)
    - 9.2.5.5.1 Spain: Overactive Bladder Treatment Market - Revenue and Forecast to 2028 (US$ Million)
    - 9.2.5.5.2 Spain: Overactive Bladder Treatment Market, by Pharmacotherapy - Revenue and Forecast to 2028 (US$ Million)
    - 9.2.5.5.2.1 Spain: Overactive Bladder Treatment Market, by Anticholinergics - Revenue and Forecast to 2028 (US$ Million)
    - 9.2.5.5.2.2 Spain: Overactive Bladder Treatment Market, by Neurostimulation - Revenue and Forecast to 2028 (US$ Million)
    - 9.2.5.5.3 Spain: Overactive Bladder Treatment Market, by Disease Type - Revenue and Forecast to 2028 (US$ Million)
  - 9.2.5.6 Rest of Europe: Overactive Bladder Treatment Market - Revenue and Forecast to 2028 (US$ Million)
    - 9.2.5.6.1 Rest of Europe: Overactive Bladder Treatment Market - Revenue and Forecast to 2028 (US$ Million)
    - 9.2.5.6.2 Rest of Europe: Overactive Bladder Treatment Market, by Pharmacotherapy - Revenue and Forecast to 2028 (US$ Million)
    - 9.2.5.6.2.1 Rest of Europe: Overactive Bladder Treatment Market, by Anticholinergics - Revenue and Forecast to 2028 (US$ Million)
    - 9.2.5.6.2.2 Rest of Europe: Overactive Bladder Treatment Market, by Neurostimulation - Revenue and Forecast to 2028 (US$ Million)
    - 9.2.5.6.3 Rest of Europe: Overactive Bladder Treatment Market, by Disease Type - Revenue and Forecast to 2028 (US$ Million)
9.3 Asia Pacific: Overactive Bladder Treatment Market
- 9.3.1 Overview
- 9.3.2 Asia Pacific: Overactive Bladder Treatment Market - Revenue and Forecast to 2028 (US$ Million)
- 9.3.3 Asia Pacific: Overactive Bladder Treatment Market, by Pharmacotherapy, 2019-2028 (US$ Million)
  - 9.3.3.1 Asia Pacific: Overactive Bladder Treatment Market, by Anticholinergic, 2019-2028 (US$ Million)
  - 9.3.3.2 Asia Pacific Overactive Bladder Treatment Market, by Neurostimulation - Revenue and Forecast to 2028 (USD Million)
- 9.3.4 Asia Pacific: Overactive Bladder Treatment Market, by Disease Type, 2019-2028 (US$ Million)
- 9.3.5 Asia Pacific: Overactive Bladder Treatment Market, by Country, 2021 & 2028 (%)
  - 9.3.5.1 China: overactive bladder treatment Market - Revenue and Forecast to 2028 (USD Million)
    - 9.3.5.1.1 China: Overactive Bladder Treatment Market - Revenue and Forecast to 2028 (US$ Million)
    - 9.3.5.1.2 China: Overactive Bladder Treatment Market, by Pharmacotherapy, 2019-2028 (US$ Million)
    - 9.3.5.1.2.1 China: Overactive Bladder Treatment Market, by Anticholinergic, 2019-2028 (US$ Million)
    - 9.3.5.1.2.2 China Overactive Bladder Treatment Market, by Neurostimulation - Revenue and Forecast to 2028 (USD Million)
    - 9.3.5.1.3 China: Overactive Bladder Treatment Market, by Disease Type, 2019-2028 (US$ Million)
  - 9.3.5.2 Japan: Overactive Bladder Treatment Market - Revenue and Forecast to 2028 (US$ Million)
    - 9.3.5.2.1 Japan: Overactive Bladder Treatment Market - Revenue and Forecast to 2028 (US$ Million)
    - 9.3.5.2.2 Japan: Overactive Bladder Treatment Market, by Pharmacotherapy, 2019-2028 (US$ Million)
    - 9.3.5.2.2.1 Japan: Overactive Bladder Treatment Market, by Anticholinergic, 2019-2028 (US$ Million)
    - 9.3.5.2.2.2 Japan Overactive Bladder Treatment Market, by Neurostimulation - Revenue and Forecast to 2028 (USD Million)
    - 9.3.5.2.3 Japan: Overactive Bladder Treatment Market, by Disease Type, 2019-2028 (US$ Million)
  - 9.3.5.3 India: Overactive Bladder Treatment Market - Revenue and Forecast to 2028 (USD Million)
    - 9.3.5.3.1 India: Overactive Bladder Treatment Market - Revenue and Forecast to 2028 (US$ Million)
    - 9.3.5.3.2 India: Overactive Bladder Treatment Market, by Pharmacotherapy, 2019-2028 (US$ Million)
    - 9.3.5.3.2.1 India: Overactive Bladder Treatment Market, by Anticholinergic, 2019-2028 (US$ Million)
    - 9.3.5.3.2.2 India Overactive Bladder Treatment Market, by Neurostimulation - Revenue and Forecast to 2028 (USD Million)
    - 9.3.5.3.3 India: Overactive Bladder Treatment Market, by Disease Type, 2019-2028 (US$ Million)
  - 9.3.5.4 South Korea: Overactive Bladder Treatment Market - Revenue and Forecast to 2028 (US$ Million)
    - 9.3.5.4.1 South Korea: Overactive Bladder Treatment Market - Revenue and Forecast to 2028 (US$ Million)
    - 9.3.5.4.2 South Korea: Overactive Bladder Treatment Market, by Pharmacotherapy, 2019-2028 (US$ Million)
    - 9.3.5.4.2.1 South Korea: Overactive Bladder Treatment Market, by Anticholinergic, 2019-2028 (US$ Million)
    - 9.3.5.4.2.2 South Korea Overactive Bladder Treatment Market, by Neurostimulation - Revenue and Forecast to 2028 (USD Million)
    - 9.3.5.4.3 South Korea: Overactive Bladder Treatment Market, by Disease Type, 2019-2028 (US$ Million)
  - 9.3.5.5 Australia: Overactive Bladder Treatment Market - Revenue and Forecast to 2028 (US$ Million)
    - 9.3.5.5.1 Australia: Overactive Bladder Treatment Market - Revenue and Forecast to 2028 (US$ Million)
    - 9.3.5.5.2 Australia: Overactive Bladder Treatment Market, by Pharmacotherapy, 2019-2028 (US$ Million)
    - 9.3.5.5.2.1 Australia: Overactive Bladder Treatment Market, by Anticholinergic, 2019-2028 (US$ Million)
    - 9.3.5.5.2.2 Australia Overactive Bladder Treatment Market, by Neurostimulation - Revenue and Forecast to 2028 (USD Million)
    - 9.3.5.5.3 Australia: Overactive Bladder Treatment Market, by Disease Type, 2019-2028 (US$ Million)
  - 9.3.5.6 Rest of Asia Pacific: Overactive Bladder Treatment Market - Revenue and Forecast to 2028 (US$ Million)
    - 9.3.5.6.1 Rest of Asia Pacific: Overactive Bladder Treatment Market - Revenue and Forecast to 2028 (US$ Million)
    - 9.3.5.6.2 Rest of Asia Pacific: Overactive Bladder Treatment Market, by Pharmacotherapy, 2019-2028 (US$ Million)
    - 9.3.5.6.2.1 Rest of Asia Pacific: Overactive Bladder Treatment Market, by Anticholinergic, 2019-2028 (US$ Million)
    - 9.3.5.6.2.2 Rest of Asia Pacific Overactive Bladder Treatment Market, by Neurostimulation - Revenue and Forecast to 2028 (USD Million)
    - 9.3.5.6.3 Rest of Asia Pacific: Overactive Bladder Treatment Market, by Disease Type, 2019-2028 (US$ Million)
9.4 Middle East & Africa: Overactive Bladder Treatment Market
- 9.4.1 Overview
- 9.4.2 Middle East & Africa: Overactive Bladder Treatment Market - Revenue and Forecast to 2028 (US$ Million)
- 9.4.3 Middle East & Africa: Overactive Bladder Treatment Market, by Pharmacotherapy, 2019-2028 (US$ Million)
  - 9.4.3.1 Middle East & Africa: Overactive Bladder Treatment Market, by Anticholinergic, 2019-2028 (US$ Million)
  - 9.4.3.2 Middle East & Africa Overactive Bladder Treatment Market, by Neurostimulation - Revenue and Forecast to 2028 (USD Million)
- 9.4.4 Middle East & Africa: Overactive Bladder Treatment Market, by Disease Type, 2019-2028 (US$ Million)
- 9.4.5 Middle East & Africa: Overactive Bladder Treatment Market, by Country, 2021 & 2028 (%)
  - 9.4.5.1 UAE: overactive bladder treatment Market - Revenue and Forecast to 2028 (USD Million)
    - 9.4.5.1.1 UAE: Overactive Bladder Treatment Market - Revenue and Forecast to 2028 (US$ Million)
    - 9.4.5.1.2 UAE: Overactive Bladder Treatment Market, by Pharmacotherapy, 2019-2028 (US$ Million)
    - 9.4.5.1.2.1 UAE: Overactive Bladder Treatment Market, by Anticholinergic, 2019-2028 (US$ Million)
    - 9.4.5.1.2.2 UAE Overactive Bladder Treatment Market, by Neurostimulation - Revenue and Forecast to 2028 (USD Million)
    - 9.4.5.1.3 UAE: Overactive Bladder Treatment Market, by Disease Type, 2019-2028 (US$ Million)
  - 9.4.5.2 Saudi Arabia: Overactive Bladder Treatment Market - Revenue and Forecast to 2028 (US$ Million)
    - 9.4.5.2.1 Saudi Arabia: Overactive Bladder Treatment Market - Revenue and Forecast to 2028 (US$ Million)
    - 9.4.5.2.2 Saudi Arabia: Overactive Bladder Treatment Market, by Pharmacotherapy, 2019-2028 (US$ Million)
    - 9.4.5.2.2.1 Saudi Arabia: Overactive Bladder Treatment Market, by Anticholinergic, 2019-2028 (US$ Million)
    - 9.4.5.2.2.2 Saudi Arabia Overactive Bladder Treatment Market, by Neurostimulation - Revenue and Forecast to 2028 (USD Million)
    - 9.4.5.2.3 Saudi Arabia: Overactive Bladder Treatment Market, by Disease Type, 2019-2028 (US$ Million)
  - 9.4.5.3 South Africa: Overactive Bladder Treatment Market - Revenue and Forecast to 2028 (USD Million)
    - 9.4.5.3.1 South Africa: Overactive Bladder Treatment Market - Revenue and Forecast to 2028 (US$ Million)
    - 9.4.5.3.2 South Africa: Overactive Bladder Treatment Market, by Pharmacotherapy, 2019-2028 (US$ Million)
    - 9.4.5.3.2.1 South Africa: Overactive Bladder Treatment Market, by Anticholinergic, 2019-2028 (US$ Million)
    - 9.4.5.3.2.2 South Africa Overactive Bladder Treatment Market, by Neurostimulation - Revenue and Forecast to 2028 (USD Million)
    - 9.4.5.3.3 South Africa: Overactive Bladder Treatment Market, by Disease Type, 2019-2028 (US$ Million)
  - 9.4.5.4 Rest of Middle East & Africa: Overactive Bladder Treatment Market - Revenue and Forecast to 2028 (US$ Million)
    - 9.4.5.4.1 Rest of Middle East & Africa: Overactive Bladder Treatment Market - Revenue and Forecast to 2028 (US$ Million)
    - 9.4.5.4.2 Rest of Middle East & Africa: Overactive Bladder Treatment Market, by Pharmacotherapy, 2019-2028 (US$ Million)
    - 9.4.5.4.2.1 Rest of Middle East & Africa: Overactive Bladder Treatment Market, by Anticholinergic, 2019-2028 (US$ Million)
    - 9.4.5.4.2.2 Rest of Middle East & Africa Overactive Bladder Treatment Market, by Neurostimulation - Revenue and Forecast to 2028 (USD Million)
    - 9.4.5.4.3 Rest of Middle East & Africa: Overactive Bladder Treatment Market, by Disease Type, 2019-2028 (US$ Million)
9.5 South and Central America: Overactive Bladder Treatment Market
- 9.5.1 Overview
- 9.5.2 South and Central America: Overactive Bladder Treatment Market - Revenue and Forecast to 2028 (USD Million)
- 9.5.3 South and Central America: Overactive Bladder Treatment Market, by Pharmacotherapy, 2019-2028 (USD Million)
  - 9.5.3.1 South and Central America: Overactive Bladder Treatment Market, by Anticholinergic, 2019-2028 (US$ Million)
  - 9.5.3.2 South & Central America Overactive Bladder Treatment Market, by Neurostimulation - Revenue and Forecast to 2028 (USD Million)
- 9.5.4 South and Central America: Overactive Bladder Treatment Market, by Disease Type, 2019-2028 (USD Million)
- 9.5.5 South and Central America: Overactive Bladder Treatment Market, by Country, 2021 & 2028 (%)
  - 9.5.5.1 Brazil: Overactive Bladder Treatment Market - Revenue and Forecast to 2028 (USD Million)
  - 9.5.5.2 Brazil: Overactive Bladder Treatment Market - Revenue and Forecast to 2028 (USD Million)
  - 9.5.5.3 Brazil: Overactive Bladder Treatment Market, by Pharmacotherapy, 2019-2028 (USD Million)
    - 9.5.5.3.1.1 Brazil: Overactive Bladder Treatment Market, by Anticholinergic, 2019-2028 (US$ Million)
    - 9.5.5.3.1.2 Brazil Overactive Bladder Treatment Market, by Neurostimulation - Revenue and Forecast to 2028 (USD Million)
  - 9.5.5.4 Brazil: Overactive Bladder Treatment Market, by Disease Type, 2019-2028 (USD Million)
- 9.5.6 Argentina: Overactive Bladder Treatment Market - Revenue and Forecast to 2028 (USD Million)
  - 9.5.6.1 Argentina: Overactive Bladder Treatment Market - Revenue and Forecast to 2028 (USD Million)
    - 9.5.6.1.1 Argentina: Overactive Bladder Treatment Market, by Pharmacotherapy, 2019-2028 (USD Million)
    - 9.5.6.1.1.1 Argentina: Overactive Bladder Treatment Market, by Anticholinergic, 2019-2028 (US$ Million)
    - 9.5.6.1.1.2 Argentina Overactive Bladder Treatment Market, by Neurostimulation - Revenue and Forecast to 2028 (USD Million)
    - 9.5.6.1.2 Argentina: Overactive Bladder Treatment Market, by Disease Type, 2019-2028 (USD Million)
  - 9.5.6.2 Rest of South and Central America: Overactive Bladder Treatment Market - Revenue and Forecast to 2028 (USD Million)
    - 9.5.6.2.1 Rest of South and Central America: Overactive Bladder Treatment Market - Revenue and Forecast to 2028 (USD Million)
    - 9.5.6.2.2 Rest of South and Central America: Overactive Bladder Treatment Market, by Pharmacotherapy, 2019-2028 (USD Million)
    - 9.5.6.2.2.1 Rest of South and Central America: Overactive Bladder Treatment Market, by Anticholinergic, 2019-2028 (US$ Million)
    - 9.5.6.2.2.2 Rest of South & Central America Overactive Bladder Treatment Market, by Neurostimulation - Revenue and Forecast to 2028 (USD Million)
    - 9.5.6.2.3 Rest of South and Central America: Overactive Bladder Treatment Market, by Disease Type, 2019-2028 (USD Million)

10. Impact Of COVID-19 Pandemic on Overactive Bladder Treatment Market

10.1 North America: Impact Assessment of COVID-19 Pandemic
10.2 Europe: Impact Assessment of COVID-19 Pandemic
10.3 Asia Pacific: Impact Assessment of COVID-19 Pandemic
10.4 South & Central America: Impact Assessment of COVID-19 Pandemic
10.5 Middle East & Africa: Impact Assessment of COVID-19 Pandemic

11. Overactive Bladder Treatment Market- Industry Landscape

11.1 Overview
11.2 Growth Strategies Done by the Companies in the Market, (%)
11.3 Organic Developments
- 11.3.1 Overview

12. Company Profiles

12.1 Alembic Pharmaceuticals Limited
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
12.2 Astellas Pharma Inc
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
12.3 AbbVie Inc
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
12.4 Teva Pharmaceutical Industries Ltd
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
12.5 Endo Pharmaceuticals Inc.
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
12.6 Hisamitsu Pharmaceutical Co.,Inc.
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Services
- 12.6.4 Financial Overview
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments
12.7 Medtronic Plc
- 12.7.1 Key Facts
- 12.7.2 Business Description
- 12.7.3 Products and Services
- 12.7.4 Financial Overview
- 12.7.5 SWOT Analysis
- 12.7.6 Key Developments
12.8 Colorado Urology Associates, PLLC
- 12.8.1 Key Facts
- 12.8.2 Business Description
- 12.8.3 Products and Services
- 12.8.4 Financial Overview
- 12.8.5 SWOT Analysis
- 12.8.6 Key Developments
12.9 Axonics Modulation Technologies, Inc
- 12.9.1 Key Facts
- 12.9.2 Business Description
- 12.9.3 Products and Services
- 12.9.4 Financial Overview
- 12.9.5 SWOT Analysis
- 12.9.6 Key Developments

13. Appendix

13.1 About The Insight Partners
13.2 Glossary of Terms

過活動膀胱治療の2028年までの市場予測-薬物療法および疾患タイプ別の世界分析

Overactive Bladder Treatment Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Pharmacotherapy and Disease Type

目次

第1章イントロダクション

第2章過活動膀胱治療の世界市場：主要なポイント

第3章調査手法

第4章過活動膀胱治療の世界市場：市場情勢

第5章過活動膀胱治療市場：主な市場力学

第6章過活動膀胱治療の世界市場：世界分析

第7章過活動膀胱治療市場の分析と2028年までの予測：薬物療法別

第8章過活動膀胱治療市場の分析と2028年までの予測：疾患タイプ別

第9章過活動膀胱治療市場の収益と2028年までの予測：地域別分析

第10章過活動膀胱治療市場へのCOVID-19パンデミックの影響

第11章過活動膀胱治療市場：業界の情勢

第12章企業プロファイル

第13章付録

List Of Tables

List Of Figures

Reasons to Buy:

Table Of Contents

1. Introduction

2. Global Overactive Bladder Treatment Market - Key Takeaways

3. Research Methodology

4. Global Overactive Bladder Treatment Market - Market Landscape

5. Overactive Bladder Treatment Market - Key Market Dynamics

6. Global Overactive Bladder Treatment Market - Global Analysis

7. Overactive Bladder Treatment Market Analysis and Forecasts To 2028 - By Pharmacotherapy

8. Overactive Bladder Treatment Market Analysis and Forecasts To 2028 - By Disease Type

9. Overactive Bladder Treatment Market Revenue and Forecasts to 2028 - Geographical Analysis

10. Impact Of COVID-19 Pandemic on Overactive Bladder Treatment Market

11. Overactive Bladder Treatment Market- Industry Landscape

12. Company Profiles

13. Appendix

過活動膀胱治療の2028年までの市場予測-薬物療法および疾患タイプ別の世界分析

Overactive Bladder Treatment Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Pharmacotherapy and Disease Type

目次

第1章 イントロダクション

第2章 過活動膀胱治療の世界市場：主要なポイント

第3章 調査手法

第4章 過活動膀胱治療の世界市場：市場情勢

第5章 過活動膀胱治療市場：主な市場力学

第6章 過活動膀胱治療の世界市場：世界分析

第7章 過活動膀胱治療市場の分析と2028年までの予測：薬物療法別

第8章 過活動膀胱治療市場の分析と2028年までの予測：疾患タイプ別

第9章 過活動膀胱治療市場の収益と2028年までの予測：地域別分析

第10章 過活動膀胱治療市場へのCOVID-19パンデミックの影響

第11章 過活動膀胱治療市場：業界の情勢

第12章 企業プロファイル

第13章 付録

List Of Tables

List Of Figures

Reasons to Buy:

Table Of Contents

1. Introduction

2. Global Overactive Bladder Treatment Market - Key Takeaways

3. Research Methodology

4. Global Overactive Bladder Treatment Market - Market Landscape

5. Overactive Bladder Treatment Market - Key Market Dynamics

6. Global Overactive Bladder Treatment Market - Global Analysis

7. Overactive Bladder Treatment Market Analysis and Forecasts To 2028 - By Pharmacotherapy

8. Overactive Bladder Treatment Market Analysis and Forecasts To 2028 - By Disease Type

9. Overactive Bladder Treatment Market Revenue and Forecasts to 2028 - Geographical Analysis

10. Impact Of COVID-19 Pandemic on Overactive Bladder Treatment Market

11. Overactive Bladder Treatment Market- Industry Landscape

12. Company Profiles

13. Appendix

第1章イントロダクション

第2章過活動膀胱治療の世界市場：主要なポイント

第3章調査手法

第4章過活動膀胱治療の世界市場：市場情勢

第5章過活動膀胱治療市場：主な市場力学

第6章過活動膀胱治療の世界市場：世界分析

第7章過活動膀胱治療市場の分析と2028年までの予測：薬物療法別

第8章過活動膀胱治療市場の分析と2028年までの予測：疾患タイプ別

第9章過活動膀胱治療市場の収益と2028年までの予測：地域別分析

第10章過活動膀胱治療市場へのCOVID-19パンデミックの影響

第11章過活動膀胱治療市場：業界の情勢

第12章企業プロファイル

第13章付録